Хайлтын үр дүнгүүд - Richard Elliott
- 24-н 1 - 20 үр дүнгүүдийг харуулж байна
- Дараагийн хуудас руу очих
-
1
Existential consumption and irrational desire -н Richard Elliott
Хэвлэсэн 1997Artigo -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
Functional Genetic Screen Identifies Increased Sensitivity to WEE1 Inhibition in Cells with Defects in Fanconi Anemia and HR Pathways -н Marieke Aarts, Ilirjana Bajrami, María Teresa Herrera-Abreu, Richard Elliott, Rachel Brough, Alan Ashworth, Christopher J. Lord, Nicholas C. Turner
Хэвлэсэн 2015Artigo -
10
BMN 673, a Novel and Highly Potent PARP1/2 Inhibitor for the Treatment of Human Cancers with DNA Repair Deficiency -н Yuqiao Shen, Farah Rehman, Ying Feng, Julia Boshuizen, Ilirjana Bajrami, Richard Elliott, Bing Wang, Christopher J. Lord, Leonard Post, Alan Ashworth
Хэвлэсэн 2013Artigo -
11
Identification of CDK10 as an Important Determinant of Resistance to Endocrine Therapy for Breast Cancer -н Elizabeth Iorns, Nicholas C. Turner, Richard Elliott, Nelofer Syed, Ornella Garrone, Milena Gasco, Andrew Tutt, Tim Crook, Christopher J. Lord, Alan Ashworth
Хэвлэсэн 2008Artigo -
12
-
13
Inactivation of Effector Caspases through Nondegradative Polyubiquitylation -н Mark Ditzel, Meike Broemer, Tencho Tenev, Clare Bolduc, Tom V. Lee, Kristoffer T. G. Rigbolt, Richard Elliott, Marketa Zvelebil, Blagoy Blagoev, Andreas Bergmann, Pascal Meier
Хэвлэсэн 2008Artigo -
14
-
15
A high-throughput screen identifies PARP1/2 inhibitors as a potential therapy for ERCC1-deficient non-small cell lung cancer -н Sophie Postel‐Vinay, Ilirjana Bajrami, Luc Friboulet, Richard Elliott, Yari Fontebasso, Nicolas Dorvault, Ken A. Olaussen, Fabrice André, J.C. Soria, Christopher J. Lord, Alan Ashworth
Хэвлэсэн 2013Artigo -
16
Harm reduction in name, but not substance: a comparative analysis of current Canadian provincial and territorial policy frameworks -н Elaine Hyshka, Jalene Anderson-Baron, Kamagaju Karekezi, Lynne Belle‐Isle, Richard Elliott, Bernie Pauly, Carol Strike, Mark Asbridge, Colleen Anne Dell, Keely McBride, Andrew D. Hathaway, T. Cameron Wild
Хэвлэсэн 2017Artigo -
17
Discovery of senolytics using machine learning -н Vanessa Smer-Barreto, Andrea Quintanilla, Richard Elliott, John C. Dawson, Jiugeng Sun, Víctor M. Campa, Álvaro Lorente‐Macías, Asier Unciti‐Broceta, Neil O. Carragher, Juan Carlos Acosta, Diego A. Oyarzún
Хэвлэсэн 2023Artigo -
18
Morphological profiling in human neural progenitor cells classifies hits in a pilot drug screen for Alzheimer’s disease -н Amina McDiarmid, Katerina Gospodinova, Richard Elliott, John C. Dawson, Rebecca E. Graham, Marie‐Thérèse El‐Daher, Susan M. Anderson, Sophie Glen, Simon Glerup, Neil O. Carragher, Kathryn L. Evans
Хэвлэсэн 2024Artigo -
19
Public support for harm reduction: A population survey of Canadian adults -н T. Cameron Wild, Jakob Koziel, Jalene Anderson-Baron, Mark Asbridge, Lynne Belle‐Isle, Colleen Anne Dell, Richard Elliott, Andrew D. Hathaway, Donald MacPherson, Keely McBride, Bernie Pauly, Carol Strike, Adam M. Galovan, Elaine Hyshka
Хэвлэсэн 2021Artigo -
20
A novel tankyrase inhibitor, MSC2504877, enhances the effects of clinical CDK4/6 inhibitors -н Malini Menon, Richard Elliott, Leandra Bowers, Nicolae Balan, Rumana Rafiq, Sara Costa-Cabral, Felix M. Munkonge, Ines Trinidade, Roderick A. Porter, Andrew D. Campbell, Emma Johnson, Christina Esdar, Hans‐Peter Buchstaller, Birgitta Leuthner, Felix Rohdich, Richard Schneider, Owen J. Sansom, Dirk Wienke, Alan Ashworth, Christopher J. Lord
Хэвлэсэн 2019Artigo
Хайх хэрэгслүүд:
Холбогдох сэдвүүд
Biology
Medicine
Cancer research
Genetics
Cancer
Cell biology
Gene
Law
Political science
Biochemistry
Internal medicine
Computer science
DNA
DNA repair
Nursing
Pathology
Pharmacology
Public health
Bioinformatics
Breast cancer
Cell cycle
Chemistry
DNA damage
Drug
Drug discovery
Gene silencing
Human immunodeficiency virus (HIV)
Kinase
Molecular biology
PARP inhibitor